Stockreport

Hikma Pharmaceuticals (LON:HIK) shareholders have endured a 29% loss from investing in the stock five years ago [Yahoo! Finance]

HIKMA PHARMS PLC S/ADR  (HKMPY) 
NASDAQ:AMEX Investor Relations: hikma.com/en/investors.html
PDF At this point some shareholders may be questioning their investment in Hikma Pharmaceuticals PLC LON:HIK ), since the last five years saw the share price fall 38%. Furth [Read more]